T. Rowe Price Associates’s ASP Isotopes ASPI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$357K Buy
80,641
+31,597
+64% +$187K ﹤0.01% 2597
2025
Q4
$263K Sell
49,044
-998,714
-95% -$7.94M ﹤0.01% 2705
2025
Q3
$10.1M Buy
1,047,758
+1,021,161
+3,839% +$9.42M ﹤0.01% 1226
2025
Q2
$196K Buy
26,597
+3,476
+15% +$23.3K ﹤0.01% 2720
2025
Q1
$109K Buy
23,121
+1,475
+7% +$7.36K ﹤0.01% 2801
2024
Q4
$99K Buy
21,646
+2,757
+15% +$14.7K ﹤0.01% 2832
2024
Q3
$53K Buy
18,889
+6,077
+47% +$16.2K ﹤0.01% 2920
2024
Q2
$0 Buy
+12,812
New +$49.4K ﹤0.01% 2928

Other funds holding ASPI

T. Rowe Price Associates's ASPI Position: Q1 2026 in Review

T. Rowe Price Associates increased its ASP Isotopes (ASPI) stake by 64% in Q1 2026, buying an estimated $187K and bringing the position to 80,641 shares worth $357K. The position accounts for ﹤0.01% of the portfolio, ranked #2597.

T. Rowe Price Associates first reported a position in ASPI in Q2 2024 and has held it in 8 quarters since. The position peaked at $10.1M in Q3 2025. 177 funds tracked by Wall St. Rank hold ASPI as of Q1 2026.

  • T. Rowe Price Associates held 80,641 shares of ASP Isotopes worth $357K as of Q1 2026.
  • T. Rowe Price Associates bought 31,597 ASP Isotopes shares in Q1 2026, an estimated $187K.
  • ASP Isotopes made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #2597 holding.
  • T. Rowe Price Associates first reported a position in ASP Isotopes in Q2 2024 and has held it in 8 quarters since.
  • T. Rowe Price Associates's ASP Isotopes position peaked at $10.1M in Q3 2025.
  • 177 funds tracked by Wall St. Rank held ASP Isotopes as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.